News
Leclanché announces its unaudited 2021 key figures
Leclanché announces its unaudited 2021 key figures
Metall Zug AG: General meeting of shareholders approves all proposals
Metall Zug AG: General meeting of shareholders approves all proposals
Baloise Group reports a robust SST ratio of 220 per cent
Baloise Group reports a robust SST ratio of 220 per cent
Burkhalter Group sells Kolb el-consult AG in Oberriet (St. Gallen)
Burkhalter Group sells Kolb el-consult AG in Oberriet (St. Gallen)
Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors
Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors
Shareholders' Meeting elects Thomas Schmuckli as Chairman of the Board of Directors
Shareholders' Meeting elects Thomas Schmuckli as Chairman of the Board of Directors
Meyer Burger is developing additional production capacity for solar modules in Germany, thereby optimizing the expansion to 1.4 gigawatts for 2023
Meyer Burger is developing additional production capacity for solar modules in Germany, thereby optimizing the expansion to 1.4 gigawatts for 2023
Annual General Meeting approves all proposals of the Board of Directors
Annual General Meeting approves all proposals of the Board of Directors
Dividend proposal approved at Mikron's Annual General Meeting amounts to CHF 0.24 per share
Dividend proposal approved at Mikron's Annual General Meeting amounts to CHF 0.24 per share
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005801/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Gurit acquires majority share in Fiberline Composites A/S
Gurit acquires majority share in Fiberline Composites A/S
SFS shareholders approve all proposals at the Annual General Meeting
SFS shareholders approve all proposals at the Annual General Meeting
Continued sales growth despite mounting challenges
Continued sales growth despite mounting challenges
Mikron shareholders approve all proposals of the Board of Directors
Mikron shareholders approve all proposals of the Board of Directors
Cicor successfully completes the acquisition of SMT Elektronik GmbH
Cicor successfully completes the acquisition of SMT Elektronik GmbH
Burkhalter Group sends invitations to Annual General Meeting and publishes pro forma financial information on planned merger
Burkhalter Group sends invitations to Annual General Meeting and publishes pro forma financial information on planned merger
Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft
Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)
94th Vifor Pharma Group Annual General Meeting
Regulatory News:
At today’s 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. The Annual General Meeting was
94. Generalversammlung der Vifor Pharma Gruppe
Regulatory News:
An der heutigen 94. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Anträge des Verwaltungsrats genehmigt. Die Generalversammlung fand erneut
Bystronic AG: Annual General Meeting approves all motions proposed by the Board of Directors
Bystronic AG: Annual General Meeting approves all motions proposed by the Board of Directors
Serial entrepreneur Miriam Wohlfarth joins TX Ventures Investment Committee
Serial entrepreneur Miriam Wohlfarth joins TX Ventures Investment Committee
Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing
Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing